PET2-Adapted Therapy in Patients With Advanced-Stage Hodgkin Lymphoma Treated With Frontline ABVD: Searching for the Baby in the Bathwater

被引：0
|
作者：
Pinto, Antonio [1 ]
Cuccaro, Annarosa [1 ]
Bonanni, Matteo [1 ]
Fresa, Alberto [1 ]
Filippi, Rosaria De [2 ]
Corazzelli, Gaetano [1 ]
机构：
[1] Ist Nazl Tumori IRCCS Fdn G Pascale, Hematol Oncol & Stem Cell Transplantat Unit, Naples, Italy
[2] Univ Federico II, Dept Clin Med & Surg, Naples, Italy
来源：
HEMATOLOGICAL ONCOLOGY | 2025年 / 43卷 / 01期
关键词：
ABVD; Hodgkin lymphoma; iPET2; therapy escalation/de-escalation; FOLLOW-UP; ESCALATED-BEACOPP; OPEN-LABEL; PHASE-II; CHEMOTHERAPY;
D O I：
10.1002/hon.70004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] PET-adapted therapy for advanced Hodgkin lymphoma - systematic review
    Amitai, Irina
    Gurion, Ronit
    Vidal, Liat
    Dann, Eldad J.
    Raanani, Pia
    Gafter-Gvili, Anat
    ACTA ONCOLOGICA, 2018, 57 (06) : 765 - 772
  • [22] PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma
    Lang, Noemie
    Crump, Michael
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [23] ADVANCED HODGKIN'S LYMPHOMA: RESULTS IN 216 PATIENTS TREATED WITH ABVD IN BRAZIL
    Britto, L.
    Biasoli, I
    Azambuja, D.
    Scheliga, A.
    Soares, A.
    Gandour, M.
    Hoffmeister, T.
    Vieites, T.
    Milito, C.
    Pulcheri, W.
    Morais, J. C.
    Spector, N.
    HAEMATOLOGICA, 2010, 95 : S18 - S19
  • [24] Making sense of cross-trial comparisons for the frontline treatment of advanced-stage Hodgkin lymphoma
    Lad, Deepesh P.
    EUROPEAN JOURNAL OF CANCER, 2020, 136 : 113 - 115
  • [25] Treatment outcome in patients with advanced-stage Hodgkin's lymphoma after developing drug intolerance to components of ABVD or BEACOPP regimens
    Bogatyreva, T.
    Kravtchenko, T.
    Strelnikova, E.
    Nestaiko, T.
    EJC SUPPLEMENTS, 2007, 5 (04): : 352 - 352
  • [26] Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)
    Kusumoto, Shigeru
    Munakata, Wataru
    Machida, Ryunosuke
    Terauchi, Takashi
    Onaya, Hiroaki
    Oguchi, Masahiko
    Iida, Shinsuke
    Nosaka, Kisato
    Suzuki, Yasuhiro
    Harada, Yasuhiko
    Miyazaki, Kana
    Maruta, Masaki
    Fukuhara, Noriko
    Toubai, Tomomi
    Kubota, Nobuko
    Ohmachi, Ken
    Yamamoto, Kazuhito
    Kumode, Takahiro
    Mizuno, Ishikazu
    Tabayashi, Takayuki
    Tsujimura, Hideki
    Takayama, Nobuyuki
    Asagoe, Kohsuke
    Yoshida, Isao
    Takamatsu, Yasushi
    Fukuhara, Suguru
    Takeuchi, Mai
    Tateishi, Ukihide
    Maruyama, Dai
    Tsukasaki, Kunihiro
    Nagai, Hirokazu
    BLOOD, 2022, 140 : 3718 - 3720
  • [27] Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (06) : 491 - 498
  • [28] G-CSF as Secondary Prophylaxis of Febrile Neutropenia In the Management of Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Decision-Analysis
    Graczyk, Joanna
    Cheung, Matthew
    Buckstein, Rena
    Chan, Kelvin
    BLOOD, 2010, 116 (21) : 1568 - 1568
  • [29] Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma
    Kobe, Carsten
    Goergen, Helen
    Baues, Christian
    Kuhnert, Georg
    Voltin, Conrad-Amadeus
    Zijlstra, Josee
    Hoekstra, Otto
    Mettler, Jasmin
    Drzezga, Alexander
    Engert, Andreas
    Borchmann, Peter
    Dietlein, Markus
    BLOOD, 2018, 132 (21) : 2273 - 2279
  • [30] Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis
    Cheung, M. C.
    Prica, A.
    Graczyk, J.
    Buckstein, R.
    Chan, K. K. W.
    LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1865 - 1875
12345